ZA200906850B - Process for production of prasugrel hydrochloride having high purity - Google Patents

Process for production of prasugrel hydrochloride having high purity

Info

Publication number
ZA200906850B
ZA200906850B ZA200906850A ZA200906850A ZA200906850B ZA 200906850 B ZA200906850 B ZA 200906850B ZA 200906850 A ZA200906850 A ZA 200906850A ZA 200906850 A ZA200906850 A ZA 200906850A ZA 200906850 B ZA200906850 B ZA 200906850B
Authority
ZA
South Africa
Prior art keywords
production
high purity
prasugrel hydrochloride
prasugrel
hydrochloride
Prior art date
Application number
ZA200906850A
Other languages
English (en)
Inventor
Hiroyuki Miyata
Yukinori Wada
Naoyuki Yokota
Original Assignee
Daiichi Sankyo Co Ltd
Ube Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39738173&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200906850(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Daiichi Sankyo Co Ltd, Ube Industries filed Critical Daiichi Sankyo Co Ltd
Publication of ZA200906850B publication Critical patent/ZA200906850B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
ZA200906850A 2007-03-02 2009-10-01 Process for production of prasugrel hydrochloride having high purity ZA200906850B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007053093 2007-03-02

Publications (1)

Publication Number Publication Date
ZA200906850B true ZA200906850B (en) 2010-06-30

Family

ID=39738173

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200906850A ZA200906850B (en) 2007-03-02 2009-10-01 Process for production of prasugrel hydrochloride having high purity

Country Status (25)

Country Link
US (2) US20100094013A1 (xx)
EP (1) EP2123656B1 (xx)
JP (1) JP5363307B2 (xx)
KR (1) KR101505212B1 (xx)
CN (2) CN101675058A (xx)
AU (1) AU2008222000B2 (xx)
BR (1) BRPI0808034A2 (xx)
CA (1) CA2679925C (xx)
CO (1) CO6210821A2 (xx)
CY (1) CY1115518T1 (xx)
DK (1) DK2123656T3 (xx)
ES (1) ES2487190T3 (xx)
HK (1) HK1136278A1 (xx)
HR (1) HRP20140668T1 (xx)
IL (1) IL200647A (xx)
MX (1) MX2009009413A (xx)
MY (1) MY151726A (xx)
NZ (1) NZ579993A (xx)
PL (1) PL2123656T3 (xx)
PT (1) PT2123656E (xx)
RU (1) RU2435776C2 (xx)
SI (1) SI2123656T1 (xx)
TW (1) TWI417295B (xx)
WO (1) WO2008108291A1 (xx)
ZA (1) ZA200906850B (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009011619A (es) 2007-04-27 2010-01-18 Cydex Pharmaceuticals Inc Formulaciones que contienen clopidogrel y eter sulfoalquilico-ciclodextrina y metodos de uso.
US20100261908A1 (en) * 2007-11-09 2010-10-14 Dr. Reddy's Laboratories Ltd. Processes for the preparation of prasugrel , and its salts and polymorphs
CN101684124B (zh) * 2008-09-22 2013-11-13 广州赫尔氏药物开发有限公司 新的具有抗凝血作用的化合物
CN103936756B (zh) * 2008-09-22 2017-09-19 广州赫尔氏药物开发有限公司 具有抗凝血作用的化合物
CN101486635B (zh) * 2009-02-27 2012-10-10 上海医药工业研究院 α-环丙基羰基-2-氟苄基卤素的制备方法
WO2010132711A1 (en) 2009-05-13 2010-11-18 Cydex Pharmaceuticals, Inc. Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
CN101993447A (zh) * 2009-08-26 2011-03-30 浙江华海药业股份有限公司 一种人工合成普拉格雷的方法
HU229031B1 (en) 2009-12-21 2013-07-29 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Process for producing prasurgel and its intermediate
HU229035B1 (en) 2009-12-21 2013-07-29 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Process for producing prasurgel
CN101735241A (zh) * 2009-12-24 2010-06-16 浙江普洛家园药业有限公司 普拉格雷中间体及其制备方法
CN102869668A (zh) 2010-03-09 2013-01-09 斯索恩有限公司 制备普拉格雷的方法
US20130053569A1 (en) * 2010-03-23 2013-02-28 Jayaraman Venkat Raman Process for the preparation of prasugrel hcl salt
WO2012001486A1 (en) * 2010-06-28 2012-01-05 Mayuka Labs Pvt. Ltd. An improved process for the preparation of prasugrel hydrochloride and its intermediates
WO2012018791A2 (en) * 2010-08-06 2012-02-09 Dr. Reddy's Laboratories Ltd. Preparation of prasugrel hydrochloride
CN101948479B (zh) * 2010-09-29 2013-01-30 横店集团家园化工有限公司 普拉格雷中间体及其制备方法
HUP1000565A2 (en) 2010-10-22 2012-05-02 Egis Gyogyszergyar Nyrt Process for the preparation of pharmaceutically active compound and intermediers
CN102101827B (zh) * 2010-11-15 2013-07-03 山东新华制药股份有限公司 一种普拉格雷中间体α-环丙羰基-2-氟苄基卤的制备方法
US9556196B2 (en) 2011-04-14 2017-01-31 Guangzhou Heershi Pharma Development Co., Ltd Anti-platelet compound addition salt
CN102746318A (zh) * 2011-04-20 2012-10-24 上海信谊药厂有限公司 用于制备普拉格雷盐酸盐的方法
CN102276623A (zh) * 2011-06-13 2011-12-14 安徽省虹升生物科技有限公司 一种利用有机硅保护剂进行制备普拉格雷的新方法
CN102838618A (zh) 2011-06-22 2012-12-26 广东东阳光药业有限公司 一种制备普拉格雷的方法及普拉格雷盐酸盐新晶型
WO2013024399A1 (en) * 2011-08-12 2013-02-21 Alembic Pharmaceuticals Limited Improved method for quantitative determination of prasugrel hydrochloride
CN102977115B (zh) * 2012-11-16 2015-01-21 江苏先声药业有限公司 普拉格雷游离碱的合成新方法
CN105085541A (zh) * 2014-05-07 2015-11-25 江苏先声药业有限公司 一种普拉格雷类似物的制备方法
HU231079B1 (hu) 2016-06-23 2020-06-29 Richter Gedeon Nyrt. Eljárás nagytisztaságú Prasugrel előállítására bromopentil szennyezés eltávolításával
CN112047959A (zh) * 2020-10-21 2020-12-08 深圳市祥根生物科技有限公司 一种普拉格雷开环氯代杂质的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI101150B (fi) * 1991-09-09 1998-04-30 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten tetrahydrotienopyridiinin johd annaisten valmistamiseksi
JP3840662B2 (ja) * 1994-10-07 2006-11-01 宇部興産株式会社 2−シリルオキシ−テトラヒドロチエノピリジン類、その塩およびその製造方法
WO2002004461A1 (fr) * 2000-07-06 2002-01-17 Sankyo Company, Limited Sels d'addition acides de dérivés hydropyridine
JP4001199B2 (ja) * 2000-07-06 2007-10-31 第一三共株式会社 ヒドロピリジン誘導体酸付加塩
PT1350511E (pt) * 2000-12-25 2008-10-28 Ube Industries Composições medicinais contendo aspirina
JP4029974B2 (ja) * 2001-12-21 2008-01-09 第一三共株式会社 ヒドロピリジン誘導体酸付加塩を含有する医薬
JP2006525328A (ja) * 2003-05-05 2006-11-09 イーライ リリー アンド カンパニー 心疾患の治療方法
TWI318571B (en) * 2005-06-10 2009-12-21 Lilly Co Eli Formulation of a thienopyridine platelet aggregation inhibitor
TWI392681B (zh) * 2006-04-06 2013-04-11 Daiichi Sankyo Co Ltd 高純度普拉格雷及其酸加成鹽之製法

Also Published As

Publication number Publication date
HRP20140668T1 (hr) 2014-10-10
CN101675058A (zh) 2010-03-17
US20130345428A1 (en) 2013-12-26
CN102424686A (zh) 2012-04-25
MY151726A (en) 2014-06-30
JPWO2008108291A1 (ja) 2010-06-17
PL2123656T3 (pl) 2014-11-28
IL200647A (en) 2015-02-26
KR101505212B1 (ko) 2015-03-23
AU2008222000B2 (en) 2012-06-14
PT2123656E (pt) 2014-09-08
NZ579993A (en) 2012-06-29
WO2008108291A1 (ja) 2008-09-12
HK1136278A1 (en) 2010-06-25
US20100094013A1 (en) 2010-04-15
CA2679925C (en) 2012-10-02
KR20090127267A (ko) 2009-12-10
SI2123656T1 (sl) 2014-09-30
BRPI0808034A2 (pt) 2014-06-17
RU2009136445A (ru) 2011-04-10
JP5363307B2 (ja) 2013-12-11
RU2435776C2 (ru) 2011-12-10
CA2679925A1 (en) 2008-09-12
EP2123656B1 (en) 2014-06-11
EP2123656A4 (en) 2011-05-04
CO6210821A2 (es) 2010-10-20
CY1115518T1 (el) 2017-01-04
ES2487190T3 (es) 2014-08-20
DK2123656T3 (da) 2014-09-08
TW200844104A (en) 2008-11-16
MX2009009413A (es) 2009-09-11
TWI417295B (zh) 2013-12-01
IL200647A0 (en) 2010-05-17
EP2123656A1 (en) 2009-11-25
AU2008222000A1 (en) 2008-09-12

Similar Documents

Publication Publication Date Title
HK1136278A1 (en) Process for production of prasugrel hydrochloride having high purity
SI2003136T1 (sl) Postopek za pridobivanje prasugrel hidroklorida visoke čistosti
EP2123625A4 (en) CRYSTALLINE POLYMORPH OF FLUORENE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME
IL191125A0 (en) Process for production of cinnamide derivative
SI2144851T1 (sl) Postopek za proizvodnjo pcc
IL199295A (en) Process for the production of an anthranilamide compound
EP2267143A4 (en) METHODS FOR PRODUCING AMIDE COMPOUNDS
EP2169075A4 (en) PREPARATION FOR ALKALOID
EP2025719A4 (en) PROCESS FOR PRODUCING AN AZO COMPOUND
EP2133356A4 (en) METHOD FOR PRODUCING A PHOSPHORUS-CONTAINING KETOSIC ACID
EP2017262A4 (en) PROCESS FOR PRODUCING CAROTENOID
EP2088136A4 (en) PROCESS FOR PRODUCING HYDROXYADAMANTANE-AMINE
EP2292579A4 (en) PROCESS FOR THE PRODUCTION OF HALOGENATED FLUOROETHERS
EP1990336A4 (en) PROCESS FOR PRODUCING A 5-ALCOXY-4-HYDROXYMETHYLPYRAZOLE COMPOUND
IL187155A0 (en) Process for production of 4-biphenylazetidin-2-ones
EP2256102A4 (en) PROCESS FOR PRODUCING ALCOXYCARBONYL COMPOUND
EP2096103A4 (en) PROCESS FOR THE PRODUCTION OF BETAINE
ZA200710066B (en) Process for production of 4-biphenylylazetidin-2-ones
EP2221294A4 (en) PROCESS FOR PREPARING N-CARBAMOYL-TERT.-LEUCIN
HK1152033A1 (en) Process for production of thiophene compound and intermediate thereof
IL200281A0 (en) Process for production of tablet
EP2216411A4 (en) METHOD FOR PRODUCING A PYRROL COMPOUND
EP2085403A4 (en) PROCESS FOR PRODUCTION OF THIOESTER PEPTIDE
EP1988073A4 (en) PROCESS FOR PRODUCING AN AMIDE-TYPE BETA-AMINO-ALPHA-HYDROXYACID DERIVATIVE
EP2251329A4 (en) PROCESS FOR THE PRODUCTION OF 3-AMINO-2-CHLORO-6-TRIFLUOROMETHYLPYRIDINE